Hemp based foods from Naturally Splendid Enterprises Ltd. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Hemp based foods from Naturally Splendid Enterprises Ltd.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: pocotrader	4/20/2014 6:30:47 PM
	Read Replies (1) of 163

CBD Treats Psychosis With Fewer Side Effects, New Study Finds According to a review published in the November issue of the journal Neuropsychopharmacology, non-psychotropic cannabinoid Cananbidiol (CBD) alleviates psychotic symptoms has high potential as an alternative treatment for psychosis. Based on the preclinical and clinical data on the use of CBD as an antipsychotic agent, investigators in the Netherlands and the UK reported that both animal and human studies document the ability of CBD to mitigate symptoms of psychosis. A 2012 study that compared the effectiveness of CBD vs. the prescription anti-psychotic drug Amisulpride in 42 subjects with schizophrenia and acute paranoia concluded that while both the agents brought about “equally significant clinical improvement”, cannabidiol “possessed significantly less side effects.” Evidence from several study domains and previous human trials suggest that considering its superior cost-effectiveness, safety, and high tolerability, CBD may prove to be an attractive alternative to current antipsychotic treatment. Preliminary clinical trials assessing the safety and tolerability of the compound in children are scheduled to begin immediately after the FDA’s recent approval of the experimental use of CBD extracts for the treatment of Dravet syndrome, a rare form of incurable pediatric epilepsy. The therapeutic qualities (anti-inflammatory, anti-diabetic, anti-epileptic, anti-cancer, and bone-stimulating properties) of CBD have been documented primarily in animal models in separate investigations of CBD. Administration of this cannabinoid is associated with improved symptoms in clinical evaluations of patients with ketamine-induced dissociative and psychotic symptoms, schizophrenia, and Parkinson’s disease. (Via StT.org Soumya Nalam Freelance writer Soumya Nalam is a former Thomson Reuters Corporation Senior Publishing Specialist and manager in Google's AdSense Online Operations Division. She has a Master's degree in Biochemistry & Molecular Biology. Follow:

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next